(Sharecast News) - Shares in medical device company Belluscura headed south early on Tuesday as it withdrew FY guidance in a statement regarding the potential impact of the imposition of tariffs on imports to the United States announced by Donald Trump last week.
Belluscura said it was "currently assessing the potential...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE